Category:
Anti-tumor Preparations
Standard:
N;
Products
Products
Suppliers
News
Search
All Categories
Products or Suppliers
Content Hub
Product Zone
Sponsorship & Membership
CPHI & PMEC China
Active Pharmaceutical Ingredients
Intermediates&Fine Chemicals
Bio Products
Natural Extracts
Finished Dosage
Pharmaceutical Excipients
Pharmaceutical Outsourcing, Customised Services, and Consulting
Medical Aesthetic Skincare
Food Ingredients
API Equipment
Preparation Equipment
Pharmaceutical Packaging Machinery
TCM Machinery
Pharmaceutical water equipment
Clean Technology
Refrigeration Equipment
Parts and Components
Informatization Products
Laboratory
Packaging Materials
Measuring Instrument
Environmental Protection Equipment
Logistics
Other Consumables
Dietary Supplements
Correctives
Colorant
Filtration separation
Intelligent Logistics
Cold chain Technical &Materials
Logistics Equipment &Materials
Storage Equipment &Materials
Logistic Services
Third-party logistics
Dangerous Goods Logistics
Level instrument
Pressure gauge
Thermometers
Flow meter
Gas analysis instrument
Liquid analysis instrument
Fermenter Equipment
Other Measuring Instrument
Other Logistics
Medical Aesthetic Consumables
Sera and Vaccines
Soft tube/Hard tube
Pharmaceutical Intermediates
Anti-tumor Preparations
Pharmaceutical Manufacturing Outsourcing
Chemical and Biochemical Reactors
Mixing Equipment
CIP System(Clean in place)
Herbal medicine Concentration Equipment
Purification Equipment
Low Temperature Refrigeration
Seals
Laboratory General Equipment
Functional Food Raw Materials
Inner packaging equipment
Polluted Water / Wastewater Treatment Equipment
Injection Raw Materials and Ingredients
IVD (In Vitro Diagnostics) Consumables
Suspending Agents / Thickening Agents
Concentrator Equipment
MES System
APIs for Anti-Infective Drugs
Biochemical APIs
Botanical products
Pharma Packaging Materials
Diluents (Fillers)
Intermediates for Agrochemicals
Reagent
Cardiovascular, Cerebrovascular, and Circulatory System Formulations
Pharmaceutical R&D Outsourcing
Drying Equipment
TCM Pulverizer
Water Purification Equipment
Purification Test Instrument
Air Conditioner
Sanitary Fittings
Analytical Instrument
Other Dipstick Consumables
Nutraceutical Ingredients
Granules Machinery
Outer packaging
Waste Gas Treatment Equipment
Active Ingredients
Binders
Solubilizers
Drug delivery systems
Sensors
APIs for Nervous System Drugs
Animal-derived products
Endocrine and Metabolic Preparations
Disintegrants
service
Crystalling Equipment
Pill Making Equipment
Other Water Treatment Equipment
Clean Clothes/Clean Cap/Clean Shoes
Cold Storage
Pumps
Food & Beverage Raw Materials
Life Science Instrument
Tablet equipment
Other pharmaceutical packaging equipment
Solid and Hazardous Waste Treatment Equipment
Innovative Materials
Controllers & Drivers
Speciality Intermediates
Microbial products
Humectants
APIs for Digestive System Drugs
APIs for Cardiovascular System Drugs
Antibacterial and Antiviral Formulations
Lubricants
Extraction Plant
Slice Machine
Clean Bench
Refrigeration Auxiliaries
Valves
Biologics
TCM Raw Materials
Food Additive
Reagents and Consumables
Capsule equipment
Pharmaceutical water equipment
Testing & Monitoring Instruments and Equipment
Other Medical Aesthetics & Skincare
Veterinary Pharmaceutical Intermediates
Automation Software
APIs for Respiratory System Drugs
Bio Technology Service
Antipyretic and Analgesic Preparations
Glidants / Anti-caking Agents
Heat Exchanger
Herbal medicine Drying Equipment
Air Shower Room
Compressor
Cylinders
Fine Chemicals
Crushing equipment
Ultrapure Water System
Other Automation & Informatization Products
OEM/ODM
Measuring Instruments
Energy-saving and Low-carbon Equipment
Other Intermediates
Antiparasitic Preparations
Coating Agents
Storage Tanks, Containers
Herbal medicine Extraction Equipment
Air Purification
Other Refrigeration Equipment
Drive Equipment
Liquid preparation equipment
Solution Preparation System
Other Environmental Protection Equipment
APIs for Hormones and Regulatory Drugs
Other Natural Products
Physical Testing
APIs for Antiparasitic Drugs
Anti-Allergic Formulations
Plasticizer
Evaporating Equipment
TCM Cooking Equipments
Cleanroom
Reducers
Laboratory Engineering
Biopharmaceutical Equipment
Membrane Module
APIs for Antipyretic and Analgesic Drugs
Anti-Tuberculosis and Anti-Leprosy Formulations
Surfactant
Distillation Equipment
Drop Pill Equipment
Purifying Engineering
VFD (Variable Frequency Drive)
Other preparation equipment
Distilled water machine
Laboratory Solutions
Vitamin
Digestive System Preparations
Centrifuge
Screening Machine
Honey Pill Machine
Flooring Materials
Bearing
Emulsifiers
Ion-exchange equipment
Online Process Control
Respiratory System Preparations
Sterilizing Equipment
TCM Deposition Equipment
Spare Part
Other Cleaning System
Stainless Steel
Nervous System Preparations
Filter press equipment
Herbal medicine Fermentation Equipment
Plastic
Containment System
Special Active Ingredients
Ointment Bases
Homogenizer Equipment
Other TCM Machinery
Others Parts and Components
APIs for Veterinary Drugs and Feed Additives
Anaesthetic and Adjuvant Formulations
Air Filter
Suppository Bases
Other Active Pharmaceutical Ingredients
Blood System Formulations
Cleanroom Consumables
Glass lining equipment
Film-forming Agents
Urinary and Reproductive System Formulations
Other API Machinery and Equipment
Filter Paper
Release Modifiers
Immunomodulatory Formulations
Filter Paper Board
smotic Pressure Regulators / Tonicity Adjusting Agents
Water, Electrolyte, and Acid-Base Balance Regulating Formulations
Ph Control Agents
Nozzle, Tank Cleaning Machine
Vitamin, Mineral, and Amino Acid Formulations
Antioxidants / Antioxidant Synergists
Fluid Equipment
Enzyme and Other Biochemical Formulations
Antimicrobial Preservatives (Preservatives)
Tonic and Nutritional Formulations
Complexing Agents (Chelating Agents / Inclusion Compounds)
Hormonal Formulations
Dermatological Preparations
Other Preparations
Co-solvents
ENT Preparations
Penetration Enhancers (Transdermal)
Freeze-drying Protective Agents
Refrigerants / Cryogens
Capsule
Fragrances
Adsorbents
Pressure-sensitive Adhesives (PSA)
Stiffening Agents
Carriers for Dry Powder Inhalers (DPI Carriers)
Other Excipients
Pipes and Pipe Fittings
Vacuum Equipment
Air Compressor
Compressor
Other Fluid Equipment
Prefillable Syringes
Filters
Filter Presstem
Filtration System
Filter Bag
Filter Mesh
Filter Cloth
Filter Membrane
Other Filtration Equipment
Sanitary Pressure Vessel
Hyaluronic Acid
Collagen
Botulinum Toxin
Peptide
Other Injection Raw Materials and Ingredients
Ceramide
Ectoin
Niacinamide
Asiaticoside
Ergothioneine
Chitosan
Other Active Ingredients
Chiral Intermediates
Advanced Intermediates
Microfiltration
Ultrafiltration
Auxiliary Equipment
Separation equipment
Metered Dose Inhalers
Dry Powder Inhalers
Penicillin
Hormones
Central Nervous System Drugs
Reagents for Biopharmaceuticals
Drug Target Discovery and Validation
Plant Extracts
Animal Extracts
Synthesis/Screening
Process Development/Optimisation/Scale-Up Production
Drug Registration and Submission Services
Ointment Filling-sealing Machine、Vacuum Mixer
Eye Drug Machinery
Soft Gelatin Capsule Machinery
Tablet Press
Pneumatic Cracker
Granulator
Labelers, Label Printers
Bag Packaging Machine
Thermostatic / Heating / Drying Equipment
Chromatography
Particle Size / Particle / Powder Analysis Instruments
Tabletop
Glass bottles & Vials
Fermentation Products
Prophylactic Biological Products
Mixing Tank/Blender
Bioreactor
Intravenous Infusion Set Assembly Equipment(Pen Assembly Equipment)
PCR
Recombinant Collagen
Alkaloids
Veterinary API
Regulated Fine Chemicals
Peptides
Balances / Weighing Scales
Online Gas Chromatography
Cephalosporins
Anesthetics
Immunology Reagents
Drug Development Technologies
Pharmaceutical Chemistry
Formulation Design
Regulatory and Compliance Consulting
Syrup Machinery
Injection Medicine Machinery
Hard Capsule Filling Machine
Coating Machine
Medicine Material Grinding Machine
Lettering machine
Box Packaging Machine
Mass Spectrometry
Laboratory Bench
Aluminum Foil
Rheometers / Viscometers
Chemical Reagents
Cleaning & Disinfection Equipment
Granulator
Emulsifier
Biological Fermentation System
Injection Molding Equipment
Exosome
Phospholipids
Prostaglandins
Veterinary Biologics
Chemical Reagents
Therapeutic Biological Products
Biochemical Reagents
Antibodies
Natural Pigments
Animal Lipids
Enzyme Preparations
Flowmeters
Online Particle Size Analyzer
Tetracycline
Amino Acids and Derivatives
Process Optimization and Testing
Nucleic Acids and Derivatives
Pre-Clinical Research
Chemical/Biological API Manufacturing
Powder Filling Machine
Oral Liquid Machinery
Low Temperature Pulverizer
Strapping machine
Paper Film Packaging Machine
Thermal Analyzers
Spectrometers
Other Measurement and Metrology Instruments
Storage Cabinets
Plastic Bottles
Other Industrial Process Control and Online Analytical Instruments
Certification
Feed Additives
Diagnostic Biological Products
Pulverizer
Coating Machine
Capsule Filling Machine
Other Mixing Equipment
Cell Engineering Equipment
Pre-filled Syringe Production Equipment
Purification Equipment
Electrophoresis/Gel Imaging/UV Detection
Regenerative Materials
Other Fine Chemicals
Cell Biology Reagents
Biological Consumables
Feed Additives
Soft Mist Inhaler
Plant Polysaccharides
Animal Proteins
Microbial Polysaccharides
Aminoglycoside
Enzymes
Molecular Biology Reagents
Clinical Trials
Intermediate Synthesis and Production
Market and Business Strategy Consulting
Suppository Drug Machinery
Powder Injection Machinery
Pharmaceutical Milling Machinery
Printing Device
Blister Packaging Machine
Environmental Test Chambers
Moisture Analyzer
Air Discharge Equipment
Rubber Stopper
Tablet Press
Other Tablet Equipment
Capsule Production Line
Isolator
Synthesis/Reaction Equipment
Microbial Detection Instrument
Composite Biomaterials
Animal Breeding Auxiliary Products
Packaging Testing Equipment
Laboratory Glassware and General Consumables
Preclinical Research Services
Nebulizer
Essential Oils
Animal Polysaccharides
Bioactive Functional Ingredients
Macrolides
Microbial / Fermentation Reagents
Proteins
Other Technology Services
Biotechnology Services
Formulation Development and Manufacturing
Other Services
Medicine Film Drug Machinery
Infusion Medicine Machinery（中文站有输液剂机械的三级分类）
Pharmaceutical Machine Milling
Instruction Booklet Folding Machine
Fan
Chromatography Consumables and Accessories
Other Physical Properties Testing Instruments
Gasket
Sample Preparation / Digestion Equipment
X-ray Structure Analysis
Safety Cabinet
Counting Machine (Tablet)
Other Capsule Filling Equipment
Disposable Biotechnology Equipment
Vacuum Packaging Machine
Laboratory Low-temperature Storage
Other Innovative Materials
Other Veterinary
Conveying equipment
Natural Spices
Bile Acids and Active Ingredients
Sulfonamides
Other Specialized Reagents
Computational Chemistry and AI-Assisted Drug Design
Clinical Trial Drug Manufacturing
Aerosol Drug Machinery
Super Micro Mill
Bottle Conveyer
Bundling Packaging Machine
Mixing/Dispersion Equipment
Other Laboratory Complete & Ancillary Equipment
Trays
Other Laboratory Consumable
Other Preparation Machinery for Solid Medcine
Centrifugal Separation System
Automatic Packaging Machine
Other Analytical Instrument
Chip System/Accessories
Cytokines
Counting Machine
Cartridge Vial
Medicinal Herbs
Bee Products
Chloramphenicols
Testing
Other Pharmaceutical Manufacturing Outsourcing
Medicine Filling Machine
Disk Type Bottle Straightening Machine
Lidding Materials
Other Crushing Equipment
Ultrafiltration/Microfiltration System
Horizontal Pillow Packaging Machine
Cartoning Machine
Auto-injector
Transfection/Cell Fusion
Track & Trace
Gas Generators / Gas Handling Equipment
Blood Products
TCM Ingredients & Slices
Animal Medicinal Materials
Lincomycin
Microbial Products
Bottle Washer
Vial Sealing Machine
Liquid Handling Equipment
Hoses and Fittings
Other Biopharmaceutical Equipment
Vertical Packaging Machine
Casing Machine
Microplate Reader/Enzyme Labeling Instrument
Analysis and Validation
Serialization System
Pen Injector
Other Anti-Infective Drug
Other Pharmaceutical R&D Outsourcing
Conveyer For Medicine Material
Spray Pump
Other Injectable Equipment
Aluminum Foil Packaging Machine
Coding Machine
Cell Analysis
Automated Assembly
Other Laboratory General Equipment
Packaging Bag Valve
Freeze Dryer
Granule packaging machine
Other Drug Delivery Device Accessories
Biological Microscope/In Vivo Imaging
Other Antibiotics
Cap Screwing Machine
Nasal Drug Delivery Devices / Nasal Spray Pumps
Printing Services
Liquid Packaging Machine
Laboratory Automation
Screw Capping Machine
Lamp Inspection Machine
Ophthalmic Drug Delivery Devices / Eye Drop Delivery Systems
Labelling
Powder Packaging Machine
Synthesizer
Heat Shrink Packaging Machine
Metal Detector
Insulin Pens / Blood Glucose Management Devices
Security Taggants & Markings
Filter Cartridge
Tablet Packaging Machine
Animal Experiment Instrument
Injection & blow molding machines
Batching system
Self-Injection Systems / Safety Protection Devices
Incubator Equipment
Printed Drugs Packaging
Box filling & sealing machine
Palletizing equipment
CIP cleaning system
Topical / Gynecological / Intimate Drug Delivery Devices
Desiccants
Other Life Science Instrument
Bottle Filling Line
Contaners
Lifting Charging Machine
Others
Inhalant Packaging
BFS Bottlepack Machine
Weighting Equipment
Blister Packaging Machine
Pharmaceutical Paper
Other Pharmaceutical Outer Packaging Equipment
Packaging bag valve
Container Sealing Machine
Glass Tube
Multi-functional Bottle Packaging Machine
Medical Aesthetic Freeze-Dried Powder Vials
Sachets Cartoner Packing line
Primary Packaging
Other Pharmaceutical Inner Packaging Equipment
Aluminum Caps & Aluminum-Plastic Combination Caps
Sterile Bags / Breathing Bags / Sterilization Bags
Medical Device Packaging / Bioconsumables Packaging
Dispensing Bottles
Blister Packaging
Pharmaceutical Plastic Films / Composite Film Bags
Accessories
Ampuls
Other Packaging Materials
Recombinant Human Endostatin
Price Range:
Get Quote
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Send inquiry
Jiangsu Simcere Pharmaceutical Co., Ltd.
6
Years
Basic Info
Is Manufacturer
No
Samples Provided
NO
Packaging & Delivery
Packaging Specification
Box Carton
Minimum Order Quantity
1,000 BOX
Product Description
Recombinant Human Endostatin Injection
Generic Name: Recombinant Human Endostatin Injection
Brand name: ENDOSTAR
Composition:
Recombinant Human Endostatin
Description:
Colorless transparent liquid. pH 5.5±0.5
Indications:
ENDOSTAR + NP chemotherapy regimen is used to treat Stage III/IV NSCLC patients either untreated or
pretreated.This indication is based on a completed multi-center Phase III clinical trial (see Clinical Studies).
Strength:
15mg/2.4×105U/3ml/vial
Dose and administration:
Add ENDOSTAR into 250~500ml NS just before the use, drip intravenously at uniform speed for 3~4h.
At combined administration with NP chemotherapy regimen, ENDOSTAR is administered continuously at
7.5mg/m2 (1.2×105U/m2) once a day during Day 1~14 of treatment cycle, and then continues the next
treatment cycle only after the rest for 1 week (generally 2~4 treatment cycles). The physician is recommended
to properly extend its administration time in clinical application within the tolerance of patients.
Adverse Reactions:
During Phase I~III clinical trial, ENDOSTAR is administered in 470 advanced NSCLC patients. The frequent
adverse reactions (1-10%) mainly occurred on heart, and rare adverse reactions (0.1-1%) mainly occurred in
digestive system and skin/annexa allergy.
1. Heart: At the early stage of administration, few patients have mild fatigue, chest distress and palpitation.
In most cases, these symptoms may improve enough so as not to influence the administration continuation
after the symptomatic treatment. But they can persist to discontinue the administration in very few cases. A
minority of cases had to stop the drug for the continuing above-mentioned symptoms. 30 patients (6.38%)
have Degree I/II or mild/moderate cardiologic adverse reactions of mainly myocardial ischemia within Day
2~7 after the administration and posing no dangers to the patient's life. 6.4‰ of these cases have more
evident but reversible symptoms, which does not influence the administration continuation but can alleviate
without any symptomatic treatment. Only 2.1‰ of the cases stop the treatment due to adverse reactions.
In the patients with previous coronary heart disease and hypertension, ENDOSTAR causes the following
frequent cardiologic adverse reactions: sinus tachycardia, mild ST-T change, AV conduction blocking, atrial
premature beat and rare ventricular premature beat. Thus, to guarantee patient safety, regular ECG
examination is recommended for the patient with cardiologic adverse reactions during clinical application.
Patient with previous serious heart diseases must use ENDOSTAR carefully under the guidance of physicians.
2. Digestive System: Rare diarrhea and liver dysfunction (mainly symptom-free transaminase elevation and
jaundice). All these adverse reactions are mainly mild/moderate but rarely serious. Most are reversible and
mild cases do not require symptomatic treatment; Moderate or serious cases may be alleviated through the
slowing of dripping speed or through the proper symptomatic treatment after drug withdrawal; and only few
cases require symptomatic treatment but generally have no influence on administration continuation.
3. Skin/Annexa: The allergy mainly includes reversible systemic maculopapule accompanied with itching
(relievable after drug withdrawal) and mostly mild/moderate fever and fatigue.No death related to adverse
reactions was observed in this multi-center clinical trial on all 470 ENDOSTAR-treated patients.
Contraindications:
Use carefully in the patient with heart/renal hypofunction.
Precautions:
1. Use carefully for the person with allergic constitution or previous allergy to protein biological products;
2. Use carefully for the patient with existing or previous serious heart diseases, including: congestive heart f
ailure, high-risk uncontrollable arrhythmia, angina pectoris requiring drug treatment, valvular disease of definite
clinical diagnosis, serious myocardial infarction on ECG and persistent hypertension. ECG examination shall
be regularly made during its clinical application, ECG monitoring performed for the patients with cardiologic
adverse reactions;
3. This product is colorless transparent liquid, and must not be used in case of abnormalities (such as turbidity
and sediment), broken packaging vial and expired.
4.When the temperature is interrupted(not more than 20ºC)during storage and transportation,the time should
not exceed 7 days,and freezing,illumination or heating shoule be avoided.
Pregnancy and lactation:
Never used in pregnant and lactating women, no previous animal experiment on its genital toxicity. Thus, use
only under the close supervision of physicians.
Pediatric use:
No previous clinical trial on its administration in pediatric patients. Used only if medication is absolutely needed
and only under the guidance of physicians.
Geriatric use:
Use only under the close observation of physicians for the old tumor patients with previous serious heart disease.
Drug interactions:
No previous systematic research on its interaction with other drugs. During the clinical application, do not mix
with other drugs or solutions possibly influencing its pH value.
Overdose:
In this clinical trial, the above-mentioned adverse reactions occur after the single intravenous drip of 30~210
mg/m2 (4.8×105~33.6×105U/m2) or after the continuous intravenous drip of 7.5~30mg/m2 (1.2×105~4.8×10
5U/m2) for 28d. There is no clinical data of higher dose.
See under section of Adverse Effect.
Clinical studies:
The National Clinical Trial Center for New Drugs (Anti-Tumor) of Cancer Hospital, Chinese Academy of
Medical Sciences, led a research team to jointly conduct a multi-center clinical trial.
Single-drug Administration: Phase II clinical trial (single-drug administration) adopts the randomly controlled,
open-labeled and multi-center research method. It mainly assesses the efficacy of ENDOSTAR, compares
the dose-efficacy relation and safety difference of 7.5mg/m2 (1.2×105U/m2) and 15mg/m2 (2.4×105U/m2),
and thus determines the optimum effective dose for clinical application. All subjects are retreated tumor p
atients pathologically and/or cytologically diagnosed definitely as non-small-cell lung cancer (NSCLC). The
subjects are divided into 7.5mg/m2 and 15mg/m2 dose group at intravenous drip for 3~12h once a day
continuously for 28d respectively. After the completion of administration, the efficacy is assessed according
to the Efficacy Evaluation Criterion on Solid Tumor (WHO). A total of 8 hospitals participates in this trial to o
bserve 68 NSCLC patients, among which 60 patients complete efficacy assessment (Table 1).
Combination treatment: A randomly controlled, double-blind and multi-center Phase III clinical trial is made on
the combined administration of ENDOSTAR and NP regimen in 493 advanced NSCLC patients.Administration
regimen of test group: 25mg/m2 NVB at Day 1 and Day 5; 30mg/m2 DDP at Day 2, Day 3, and Day 4; and
7.5mg/m2 (1.2×105U/m2) ENDOSTAR continuously during Day 1~14. Administration regimen
of control group: 25mg/m2 NVB at Day 1 and Day 5; 30mg/m2 DDP at Day 2, Day 3, and Day 4; and normal
saline (NS) during Day 1~14. The endpoint research index includes: response rate(CR+PR/total cases×100%)
clinical benefit rate (CR+PR+MR+SD/total cases×100%), TTP, median survive time, one-year survival rate,
quality of life (QOL) and safety. There are 486 cases with evaluable efficacy, i.e. test group: control
group =322:164 (cases), and untreated: pretreated =347:139 (cases). (Table 2) .
Pharmacology and toxicology:
1. Pharmacological action
Rh-Endostatin is a new angiogenesis-inhibiting biological product. It inhibits the metastasis of angiogenesis
endothelial cells, inhibits the formation of tumor new blood vessel, obstructs the nutrition supply of tumor cells,
and thus inhibits the proliferation or metastasis of tumor.As shown by in vitro test results, ENDOSTAR inhibits
the metastasis of HHEC and the formation of Tube, significantly inhibits the angiogenesis of chicken embryo
allantoic membrane. Thus, ENDOSTAR suppresses angiogenesis in vitro to a certain extent. In addition, it
inhibits the growth of human lung adenocarcinoma cells SPC-A4 to a certain extent.As shown by in vivo test
results, ENDOSTAR has extensive effects of inhibiting the mouse tumor model (S180 sarcoma, H22 liver
cancer) and human xenograft tumor (SPC-A4 lung adenocarcinoma, SGC7901 stomach cancer, Hela cervical
carcinoma, SMMC-7721 and Bel7402 liver cancer).
2. Toxicological action
General Pharmacology: After the intravenous injection of 1.5, 3 and 6mg/kg (2.4×104 - 4.8×104, and 9.6×104
U/kg)(high, medium and low dose group) , such parameters as blood pressure, respiration, and ECG index,
etc. of anaesthetized dog remains same to those before the injection, and the autonomic activity frequency
of mouse is not influenced.Hemolysis, Irritation,Allergy in Animal: There is no hemolysis or hemagglutinationin
during the observationtime after the administration of 0.08mg/ml ENDOSTAR; guinea-pig had no allergic
reactions after first the intraperitoneal injection of 0.5ml/guinea-pig (0.036mg/ml) every other day continuously
for 3 times and then the 1ml/guinea-pig (0.036mg/ml) 14d and 21d after the first administration; and rabbit had
no evident irritant reactions (such as vasodilatation and red swelling) or morphological changes (as vascular
wall thickening) in venous irritation test.
Acute Toxicity: Mouse had a LD50 of more than 450.5mg (7.2×106 U)/kg after the intravenous or
intraperitoneal administration of ENDOSTAR.
Long-term Toxicity: As shown by long-term toxicity test on rat, at the end of 21d after the withdrawal of
continuous intraperitoneal injection of 3, 6, and 12mg/kg/day (4.8×104, 9.6×104, and 19.2×104U/kg/day) for
45d respectively, all these three dose groups are not significantly different from control group in the
pathomorphological changes of internal organs (such as heart, liver, spleen, lung, brain, stomach, small
intestine, uterus and testicle).
As shown by long-term toxicity test on beagle dog, after the continuous intravenous injection of 2, 10 and
25mg/kg/day (3.2×104, 16.0×104, and 40.0×104U/kg/day) for 13 weeks respectively, beagle dog does not
have evident toxic reactions on target organs or delayed toxic reactions, but only have the adverse reaction
of elevated reticuloerythrocyte which is reversible after the drug withdrawal.
As shown by long-term toxicity test on rhesus, after the continuous intravenous injection of 3mg (4.8×104U)/
kg/day (50.4mg/m2), 10mg(1.6×105U)/kg/day (167.9mg/m2), and 30mg (4.8×105U)/kg/day (503.7mg/m2)
continuously for 9 months respectively, each dose group had no evident abnormal change in vital signs,
appearance behavior, and activities; its examination results fluctuated within the range of normal value for
weight, food intake, and hematological/blood biochemical/ECG/urine examination (i.e. no evident impairment
liver and renal function; it had basically normal protein, fat, and glucose metabolism; and it is not significantly
different in organ coefficient and had no dose-related abnormal change according to the histopathological
results. In brief, no evident toxic reactions occur after the continuous intravenous injection of less than 30mg
(4.8×105U)/kg/day, and thus such dose range is safe for ENDOSTAR.
Pharmacokinetics:
After the single intravenous drip of 30mg (4.8×105U)/m2 and 60mg (9.6×105U)/m2 within 30min (at a speed
of 1 and 2mg/m2/min respectively) and of 120mg (19.2×105U)/m2 and 210mg (33.6×105U)/m2 within 120min
(at a speed of 1 and 1.75mg/m2/min respectively) in health volunteer, ENDOSTAR has a terminal clearance
half-life (t1/2) of about 10h and a systemic clearance rate (CLs) of about 2.8L/h/m2. In normal human body,
ENDOSTAR follows approximately the linear pharmacokinetics within the dose range of 30~120mg/m2 (4.8×
105~19.2×105U/m2). The linear model can be used to predict the blood drug concentration at different total
dose, dripping speed and dripping time, which can influence AUC and maximum concentration level.
In tumor patient, ENDOSTAR shows great inter-individual difference in drug concentration-time curve after the
daily intravenous drip within 2h continuously for 28d.The minimum concentration tends to increase continuously
with the increase in administration times, and both total dose and dripping times can influence both the peak
and trough concentrations.
After the intravenous administration of in normal mouse, the drug concentration is highest in urinary excretory
system, higher in kidney, urine, lung and liver than in plasma, lower in other tissues than in plasma, and lowest
in muscle, fat, and brain. After the intravenous injection in tumor mouse, the systemic distribution ENDOSTAR
is similar to that in normal mouse, its low distribution in tumor tissue is similar to that in muscle and fat tissue.
Antibody generation:
The antibody IgG serum is detected through indirect ELISA method the intravenous injection of ENDOSTAR
continuously for 9 months in rhesus. The antibody generated after the administration is related to both dose
and time: the higher dose generates the higher-titer antibody in more rhesuses. The antibody can be detected
1 month after the administration. The antibody titer varies with time: more stable in first 3 months before the
administration, and less and even no at Month 5, 7, 9, and 10. As analyzed through the cell viability detection
method, the ENDOSTAR viability in serum does not change at all, and thus the generated antibody is not
neutralizing antibody.Various ENDOSTAR antibodies (IgA, IgG, IgM, and IgE) and His-tag antibody are
detected through the same above antibody detection method in patient serum. 31 subjects undergo this
detection, including 20 cases from treatment group and 11 cases from control group. In treatment group,
2 cases have positive ENDOSTAR IgA on Day 32 and Month 24 respectively, and 1 case had positive His-tag
IgA, both at a titer of 1:10. In control group, 2 cases have positive IgG at a titer of 1:10. Any other patient does
not have antibody reaction after the treatment. The in vitro test on low-titer (1:10) serum antibody does not
show any biological activity to neutralize ENDOSTAR.
Storage:
Keep at 2~8ºC in a dark place
Package:
Filled in 3.0ml Pre-embedded syringe.
Shelf-life:
18 months
Other Products From This Supplier
More
Follow Us
Contact Us
About Us
Buy Service
Sell Service
Follow Us
Copyright 2006-2025 
(All Rights Reserved)
(All Rights Reserved)
Copyright 2006-2025 (All Rights Reserved)
(All Rights Reserved)